Create a 30 slide presentation on telmisartan use in Ischemic nephropathy, state what the standard guidelines recommends and a says as well
Create a 30 slide presentation on telmisartan use in Ischemic nephropathy, state what the standard guidelines recommends and a says as well
Created using ChatSlide
This overview addresses ischemic nephropathy and renovascular disease, detailing the role of telmisartan as an ARB and its effects on blood pressure and renal function. It compares guidelines from KDIGO, AHA/ACC, and ESC for patient selection, emphasizing monitoring parameters. Practical management is illustrated through a case study, culminating in a clinical decision pathway that weighs the benefits and risks of treatment options, including revascularization.